Pear Therapeutics Explores Strategic Options; May Seek Reorganization If Unable To Complete Transaction

  • Pear Therapeutics Inc PEAR is engaged in a process to explore strategic alternatives.
  • The company has engaged MTS Health Partners, L.P., to act as its exclusive financial advisor to assist in evaluating potential alternatives. 
  • Pear is exploring the potential for an acquisition, company sale, merger, divestiture of assets, licensing, or other strategic transactions and/or seeking additional financing as part of its process. 
  • If the company cannot complete a transaction, it may be required to seek a reorganization, liquidation, or other restructuring. 
  • Last month, Pear Therapeutics expanded its collaboration with BrightView Health, an addiction treatment provider offering evidence-based, outpatient treatment programs. 
  • This initiative is designed to provide access to reSET and reSET-O. 
  • reSET is intended to provide cognitive behavioral therapy as an adjunct to a contingency management system. It is used as a monotherapy for adult patients with substance use disorder.
  • reSET-O is used with buprenorphine-based medication-assisted treatment for patients 18 or older with opioid use disorder.
  • Price Action: PEAR shares are down 18.48% at $0.4835 on the last check Friday.
  • Photo Via Company
Posted In: BiotechNewsPenny StocksHealth CareMoversGeneralBriefs